Drug Designing and Biomarkers

Drug designing is an inventive process to find new medication centred on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This type of modelling is often mentioned to as computer-aided drug design.
biomarker is an attribute that can be studied as an indicator of pathogenic and biological operation along with pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity in the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.

  • Drug targets
  • Ligand-based design
  • Structure-based design
  • Computer-aided drug design
  • Scoring functions

Related Conference of Drug Designing and Biomarkers

January 19-20, 2026

17th International Conference on Biofuels and Bioenergy

Barcelona, Spain
May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
July 23-24, 2026

22nd World Congress on Structural Biology

Aix-en-Provence, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

Barcelona, Spain

Drug Designing and Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in